The Journal of Immunology, Vol 157, Issue 5 1905-1912, Copyright © 1996 by American Association of Immunologists

ARTICLES

Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells

MM Kosiewicz and JW Streilein
Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114, USA.

Intraocular injection of exogenous protein induces an Ag-specific impairment of systemic delayed hypersensitivity (DH), termed anterior chamber associated immune deviation (ACAID). The ACAID-inducing signal is carried by blood-borne cells from the eye to the spleen and can also be generated in vitro by incubating APCs with Ag plus TGF-beta. Paradoxically, class I-restricted CD8 regulatory cells are induced in the spleens of mice with ACAID, and previous studies suggest that CD8 cells are important, and even necessary, for the expression of ACAID. To explore this issue further, we asked whether ACAID could be induced with a class II-restricted peptide, and if so, what type of regulatory cells are generated. An intraocular, but not an i.v., injection of OVA (323-339) peptide resulted in impairment of native OVA-specific DH in both naive and previously sensitized mice. Furthermore, i.v. injection of APCs pretreated with TGF-beta plus OVA peptide also prevented native OVA-specific DH. Surprisingly, both CD8+ and CD4+ spleen cells capable of impairing expression of DH were induced by either intraocular injection of peptide or i.v. injection of APCs pretreated with peptide plus TGF-beta. In summary, ACAID can be induced by a class II- restricted peptide and is accompanied by the generation of two unusual populations of cells: 1) CD8+ regulatory cells unexpectedly induced by class II-restricted peptide; and 2) a novel population of CD4 regulatory cells induced by peptide, but not native protein. Potential mechanisms involved in the processing and presentation of exogenous protein in the ACAID model are discussed in light of the present data.

This article has been cited by other articles:

				X. Wu, K. Roelofs-Haarhuis, J. Zhang, M. Nowak, L. Layland, E. Jermann, and E. Gleichmann Dose dependence of oral tolerance to nickel Int. Immunol., August 13, 2007; (2007) dxm066v1. [Abstract] [Full Text] [PDF]

				J. Zhang-Hoover, P. Finn, and J. Stein-Streilein Modulation of Ovalbumin-Induced Airway Inflammation and Hyperreactivity by Tolerogenic APC J. Immunol., December 1, 2005; 175(11): 7117 - 7124. [Abstract] [Full Text] [PDF]

				M. M. Kosiewicz, P. Alard, S. Liang, and S. L Clark Mechanisms of tolerance induced by transforming growth factor-{beta}-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand Int. Immunol., May 1, 2004; 16(5): 697 - 706. [Abstract] [Full Text] [PDF]

				S. Camelo, A. Shanley, A. S. P. Voon, and P. G. McMenamin The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye J. Immunol., May 1, 2004; 172(9): 5388 - 5395. [Abstract] [Full Text] [PDF]

				P. Alard, S. L. Clark, and M. M. Kosiewicz Deletion, but not anergy, is involved in TGF-{beta}-treated antigen-presenting cell-induced tolerance Int. Immunol., August 1, 2003; 15(8): 945 - 953. [Abstract] [Full Text] [PDF]

				A.-C. Field, L. Caccavelli, M.-F. Bloch, and B. Bellon Regulatory CD8+ T Cells Control Neonatal Tolerance to a Th2-Mediated Autoimmunity J. Immunol., March 1, 2003; 170(5): 2508 - 2515. [Abstract] [Full Text] [PDF]

				D. E. Faunce and J. Stein-Streilein NKT Cell-Derived RANTES Recruits APCs and CD8+ T Cells to the Spleen During the Generation of Regulatory T Cells in Tolerance J. Immunol., July 1, 2002; 169(1): 31 - 38. [Abstract] [Full Text] [PDF]

				A.-C. Field, L. Caccavelli, J. Fillion, J. Kuhn, C. Mandet, P. Druet, and B. Bellon Neonatal induction of tolerance to Th2-mediated autoimmunity in rats Int. Immunol., October 1, 2000; 12(10): 1467 - 1477. [Abstract] [Full Text] [PDF]

				T. Kezuka and J. W. Streilein In Vitro Generation of Regulatory CD8+ T Cells Similar to those Found in Mice with Anterior Chamber-Associated Immune Deviation Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1803 - 1811. [Abstract] [Full Text]

				T. Kezuka and J. W. Streilein Analysis of In Vivo Regulatory Properties of T Cells Activated In Vitro by TGF{beta}2-Treated Antigen Presenting Cells Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1410 - 1421. [Abstract] [Full Text]

				K. Kawahata, Y. Misaki, Y. Komagata, K. Setoguchi, S. Tsunekawa, Y. Yoshikawa, J.-i. Miyazaki, and K. Yamamoto Altered Expression Level of a Systemic Nuclear Autoantigen Determines the Fate of Immune Response to Self J. Immunol., June 1, 1999; 162(11): 6482 - 6491. [Abstract] [Full Text] [PDF]